Clinical trials
Phase 2 Diabetes Mellitus, Type 2 trials in Latvia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 4 |
| Boehringer Ingelheim | 3 |
| GlaxoSmithKline | 3 |
| AstraZeneca | 2 |
| Afimmune | 1 |
| Genfit | 1 |
| Poxel SA | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 16 |
| Diabetes Mellitus | 2 |
| Glucose Metabolism Disorders | 2 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Lipoatrophic | 1 |
| Dyslipidemias | 1 |
| Exocrine Pancreatic Insufficiency | 1 |
| Hyperglycemia | 1 |
| Hypertriglyceridemia | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.